2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, Montefiore Medical Center, discusses unmet needs in metastatic breast cancer.
This remains an incurable disease, Sparano says, although there have been significant improvements in clinical outcomes over the last few years. For patients with estrogen receptor-positive, HER2-negative disease, the rise of CDK4/6 inhibitors has dramatically changed the management of that setting. These agents haven
Related Content: